iBio, Inc. has agreed to license its iBioLaunch technology platform and provide technology transfer services to G-Con, LLC for the development and manufacture of plant-expressed influenza vaccines at a new facility in Bryan, TX. The “GreenVax Project” will show proof of concept for a large-scale vaccine production facility using Nicotiana plants grown hydroponically in a contained environment. According to iBio, its green plant technology platform has the potential to shorten vaccine production ...